Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas

Disease Sites:

Not Available

Staging:

Phase II

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Esbenshade, Adam

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

02-11-2025

Trial Type:

Treatment

Protocol ID:

COGACNS2321

National Clinical Trial ID:

NCT06368817

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available